Neopharm Reports Operating Profit of 23 Billion KRW Last Year, Up 19.8% Year-on-Year
[Asia Economy Reporter Choi Saeng-hye] NeoPharm, a company listed on KOSDAQ, announced on the 7th that its consolidated operating profit for the past year was tentatively estimated at 23 billion KRW, an increase of 19.8% compared to the previous year.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
Sales amounted to 83.2 billion KRW, up 25.6% from the previous year. Net profit increased by 16.8% to 18 billion KRW. Operating profit for the fourth quarter was 5.6 billion KRW, down 2.2% from the same period last year. Sales and net profit for this quarter were 22.8 billion KRW and 4.6 billion KRW, respectively.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
